From research beginnings through to commercially viable companies, Swinburne’s research and technologies translate to bring innovative products and services to market. The following start-ups and spin-off companies originated at Swinburne and have gone on to become commercial ventures.
Innovative start-up mDetect has developed a new technology platform that uses particles from space – called muons – to ‘see the unseeable’. The platform can visualise conditions underground, underwater or within structures providing valuable intelligence. Research began at Swinburne in 2018, was further developed through Swinburne's Accelerator Program and deployed to upgrade Melbourne’s water utilities in 2020.
Nirtek has developed a ground-breaking medical device to identify those at the highest risk of a heart attack. An infrared laser developed by researchers at the Baker Heart and Diabetes Institute and Swinburne University can differentiate between plaques that are stable and unstable for the first time, preventing rupture and heart attack.
Founded in 2017, Capsular Technologies has developed a slow-release veterinary vaccine, eliminating the need for booster shots. The technology uses a micro-hydrogel to slowly release immune-boosting components, which prolongs and increases the effectiveness of a single vaccine injection.
Hearables 3D is a start-up that draws on Swinburne research to scan and 3D print customised tips, tailored to individuals’ unique ear profile. The result is better-fitting earphones and hearing aids.